Background-Short chain fatty acid (SCFA) deficiency is associated with
colitis in animals and humans, and the mucosal metabolism of these co
mpounds is decreased in ulcerative colitis. Aims-To assess the efficac
y of topical SCFA treatment in ulcerative colitis. Patients and Method
s-103 patients with distal ulcerative colitis were entered into a six
week, double-blind, placebo controlled trial of rectal SCFA twice dail
y; patients who were unchanged on placebo were offered SCFA in an open
-label extension trial. Results-Of the 91 patients completing the tria
l, more patients in the SCFA treated than in the placebo treated group
improved (33% v 20%, p=0.14, NS). Those on SCFA also had larger, but
statistically non-significant, reductions in every component of their
clinical and histological activity scores. In patients with a relative
ly short current episode of colitis (<6 months, n=42), more responded
to SCFA than to placebo (48% v 18%, p=0.03). These patients also had l
arger, but statistically non-significant, decreases in their clinical
activity index (p=0.08 v placebo). Every patient who improved used at
least five of six of the prescribed rectal SCFA irrigations, whereas o
nly 37% who did not improve were as compliant. In the open-label exten
sion trial, 65% improved on SCFA; these patients also had significant
reductions (p<0.02) in their clinical and histological activity scores
. Conclusions-Although SCFA enemas were not of therapeutic value in th
is controlled trial, the results suggest efficacy in subsets of patien
ts with distal ulcerative colitis including those with short active ep
isodes. Prolonged contact with rectal mucosa seems to be necessary for
therapeutic benefit.